104 related articles for article (PubMed ID: 33885338)
1. Plasma Cytokine Levels As Predictors of Global and Domain-Specific Human Immunodeficiency Virus-Associated Neurocognitive Impairment in Treatment-Naive Individuals.
Ruhanya V; Jacobs GB; Paul R; Joska J; Seedat S; Nyandoro G; Engelbrecht S; Glashoff RH
J Interferon Cytokine Res; 2021 Apr; 41(4):153-160. PubMed ID: 33885338
[TBL] [Abstract][Full Text] [Related]
2. Blood-based inflammation biomarkers of neurocognitive impairment in people living with HIV.
Swanta N; Aryal S; Nejtek V; Shenoy S; Ghorpade A; Borgmann K
J Neurovirol; 2020 Jun; 26(3):358-370. PubMed ID: 32193795
[TBL] [Abstract][Full Text] [Related]
3. Higher soluble CD14 levels are associated with lower visuospatial memory performance in youth with HIV.
Kim-Chang JJ; Donovan K; Loop MS; Hong S; Fischer B; Venturi G; Garvie PA; Kohn J; Rendina HJ; Woods SP; Goodenow MM; Nichols SL; Sleasman JW;
AIDS; 2019 Dec; 33(15):2363-2374. PubMed ID: 31764101
[TBL] [Abstract][Full Text] [Related]
4. Impact of Plasma IP-10/CXCL10 and RANTES/CCL5 Levels on Neurocognitive Function in HIV Treatment-Naive Patients.
Ruhanya V; Jacobs GB; Naidoo S; Paul RH; Joska JA; Seedat S; Nyandoro G; Engelbrecht S; Glashoff RH
AIDS Res Hum Retroviruses; 2021 Sep; 37(9):657-665. PubMed ID: 33472520
[TBL] [Abstract][Full Text] [Related]
5. Neurocognitive dysfunction in HIV-infected youth: investigating the relationship with immune activation.
Eckard AR; Rosebush JC; O'Riordan MA; Graves CC; Alexander A; Grover AK; Lee ST; Habib JG; Ruff JH; Chahroudi A; McComsey GA
Antivir Ther; 2017; 22(8):669-680. PubMed ID: 28327462
[TBL] [Abstract][Full Text] [Related]
6. Neurocognitive Impairment in the Combined Antiretroviral Therapy Era in a Romanian Cohort of Young Adults with Chronic HIV Infection.
Temereanca A; Ene L; Rosca A; Diaconu CC; Luca A; Burlacu R; Radoi R; Bulacu-Talnariu A; Marcotte TD; Achim CL; Ruta S
AIDS Res Hum Retroviruses; 2020 May; 36(5):367-372. PubMed ID: 31476875
[TBL] [Abstract][Full Text] [Related]
7. Relation of Steatosis to Neurocognitive Function in People Living with HIV.
Marić D; Brkić S; Ignjatović VB; Nikolaševic Ž; Ilić D; Vujanović M; Drvendžija Z; Galić BS
Curr HIV Res; 2020; 18(3):172-180. PubMed ID: 32106801
[TBL] [Abstract][Full Text] [Related]
8. Peripheral blood lymphocyte proviral DNA predicts neurocognitive impairment in clade C HIV.
Ruhanya V; Jacobs GB; Nyandoro G; Paul RH; Joska JA; Seedat S; Glashoff RH; Engelbrecht S
J Neurovirol; 2020 Dec; 26(6):920-928. PubMed ID: 32737863
[TBL] [Abstract][Full Text] [Related]
9. Cytokines, Hepatic Fibrosis, and Antiretroviral Therapy Role in Neurocognitive Disorders HIV Related.
Falasca K; Reale M; Ucciferri C; Di Nicola M; Di Martino G; D'Angelo C; Coladonato S; Vecchiet J
AIDS Res Hum Retroviruses; 2017 Mar; 33(3):246-253. PubMed ID: 27615271
[TBL] [Abstract][Full Text] [Related]
10. (1→3)-β-D-Glucan Levels Correlate With Neurocognitive Functioning in HIV-Infected Persons on Suppressive Antiretroviral Therapy: A Cohort Study.
Hoenigl M; de Oliveira MF; Pérez-Santiago J; Zhang Y; Morris S; McCutchan AJ; Finkelman M; Marcotte TD; Ellis RJ; Gianella S
Medicine (Baltimore); 2016 Mar; 95(11):e3162. PubMed ID: 26986173
[TBL] [Abstract][Full Text] [Related]
11. Latent Toxoplasma Infection and Higher Toxoplasma gondii Immunoglobulin G Levels Are Associated With Worse Neurocognitive Functioning in HIV-Infected Adults.
Bharti AR; McCutchan A; Deutsch R; Smith DM; Ellis RJ; Cherner M; Woods SP; Heaton RK; Grant I; Letendre SL
Clin Infect Dis; 2016 Dec; 63(12):1655-1660. PubMed ID: 27794019
[TBL] [Abstract][Full Text] [Related]
12. Viral and inflammatory markers in cerebrospinal fluid of patients with HIV-1-associated neurocognitive impairment during antiretroviral treatment switch.
Tiraboschi JM; Muñoz-Moreno JA; Puertas MC; Alonso-Villaverde C; Prats A; Ferrer E; Rozas N; Maso M; Ouchi D; Martinez-Picado J; Podzamczer D
HIV Med; 2015 Jul; 16(6):388-92. PubMed ID: 25721471
[TBL] [Abstract][Full Text] [Related]
13. Peripheral blood lymphocyte HIV DNA levels correlate with HIV associated neurocognitive disorders in Nigeria.
Jumare J; Sunshine S; Ahmed H; El-Kamary SS; Magder L; Hungerford L; Burdo T; Eyzaguirre LM; Umlauf A; Cherner M; Abimiku A; Charurat M; Li JZ; Blattner WA; Royal W
J Neurovirol; 2017 Jun; 23(3):474-482. PubMed ID: 28243867
[TBL] [Abstract][Full Text] [Related]
14. Lower Interferon Regulatory Factor-8 Expression in Peripheral Myeloid Cells Tracks With Adverse Central Nervous System Outcomes in Treated HIV Infection.
D'Antoni ML; Kallianpur KJ; Premeaux TA; Corley MJ; Fujita T; Laws EI; Ogata-Arakaki D; Chow DC; Khadka VS; Shikuma CM; Ndhlovu LC
Front Immunol; 2019; 10():2789. PubMed ID: 31849969
[TBL] [Abstract][Full Text] [Related]
15. Plasma concentrations of transforming growth factor beta 1 in non-progressive HIV-1 infection correlates with markers of disease progression.
Maina EK; Abana CZ; Bukusi EA; Sedegah M; Lartey M; Ampofo WK
Cytokine; 2016 May; 81():109-16. PubMed ID: 26986868
[TBL] [Abstract][Full Text] [Related]
16. Increased cell-free mitochondrial DNA is a marker of ongoing inflammation and better neurocognitive function in virologically suppressed HIV-infected individuals.
Pérez-Santiago J; De Oliveira MF; Var SR; Day TRC; Woods SP; Gianella S; Mehta SR
J Neurovirol; 2017 Apr; 23(2):283-289. PubMed ID: 27921220
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-37 Expression Is Increased in Chronic HIV-1-Infected Individuals and Is Associated with Inflammation and the Size of the Total Viral Reservoir.
Højen JF; Rasmussen TA; Andersen KL; Winckelmann AA; Laursen RR; Gunst JD; Møller HJ; Fujita M; Østergaard L; Søgaard OS; Dinarello CA; Tolstrup M
Mol Med; 2015 Apr; 21(1):337-45. PubMed ID: 25879630
[TBL] [Abstract][Full Text] [Related]
18. Relationship of plasma cytokines and clinical biomarkers to memory performance in HIV.
Correia S; Cohen R; Gongvatana A; Ross S; Olchowski J; Devlin K; Tashima K; Navia B; Delamonte S
J Neuroimmunol; 2013 Dec; 265(1-2):117-23. PubMed ID: 24210837
[TBL] [Abstract][Full Text] [Related]
19. The relationship of CSF and plasma cytokine levels in HIV infected patients with neurocognitive impairment.
Yuan L; Liu A; Qiao L; Sheng B; Xu M; Li W; Chen D
Biomed Res Int; 2015; 2015():506872. PubMed ID: 25821806
[TBL] [Abstract][Full Text] [Related]
20. Cerebrospinal fluid biomarkers and HIV-associated neurocognitive disorders in HIV-infected individuals in Rakai, Uganda.
Abassi M; Morawski BM; Nakigozi G; Nakasujja N; Kong X; Meya DB; Robertson K; Gray R; Wawer MJ; Sacktor N; Boulware DR
J Neurovirol; 2017 Jun; 23(3):369-375. PubMed ID: 27995575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
